プロトセラ List of Products and Services

ProtoCell Inc. continues to provide tests and proprietary technologies utilizing the results of peptide dome analysis research as services for preventive medicine. Our ProtoKey cancer risk test starts with biomarker discovery through joint research with universities and realizes delivery to the market. Our in-house laboratory and hygiene testing facility are equipped with advanced experimental equipment, and we have research and development, testing, sales, and business development departments, allowing us to consistently carry out everything from research and development to service provision. 【Business Activities】 ■ Clinical testing contract business (testing contract services at our registered hygiene testing facility, proprietary cancer risk tests, etc.) ■ Research and development support business (contract services such as peptide marker discovery) *For more details, please download the PDF or feel free to contact us.

• Other Analysis

The "BLOTCHIP-MS method" is an analytical technique that simplifies the process from one-dimensional electrophoresis to mass spectrometry, using a new measurement plate (BLOTCHIP) designed for high-speed processing of large sample volumes in MALDI-TOF-MS. Proteins that interfere with peptide mass analysis and high concentrations of salts that may contaminate the extraction process from biological tissues are completely removed during the one-dimensional electrophoresis step. The peptides in the gel are transferred to the BLOTCHIP in a single step via electroblotting, establishing a high-speed peptide analysis method that omits the complicated steps of conventional methods. The BLOTCHIP-MS method can be applied to various peptide research purposes beyond biomarker development. 【Features】 ■ Simple pretreatment ■ Less target loss compared to conventional methods since no protein removal is performed ■ Quantitative analysis is possible if the target peptides are known *For more details, please download the PDF or feel free to contact us.

• others

The "HepaSign Liver Disease Risk Test" is a blood test that checks the degree of inflammation in the liver. It evaluates the risk of liver disease in three stages based on the measurement of CK-18F in the blood. By understanding your current liver disease risk, you can identify appropriate measures such as lifestyle improvements and undergoing secondary examinations. Taking early action can lead to early detection and improvement of liver function. 【Key Points】 - Risk check at an early stage before liver fibrosis or cirrhosis occurs. - Measures substances produced during the apoptosis process of liver cells, increasing the possibility of early detection of inflammation. - The test can be conducted quickly with just a blood sample. - No dietary restrictions are required. *For more details, please download the PDF or feel free to contact us.*

• Contract Inspection

The "Protokey Cancer Risk Test" measures peptides in the blood that have shown changes in cancer patients, evaluating the current risks of colorectal cancer and pancreatic cancer. The current risks of colorectal cancer and pancreatic cancer are assessed on a three-tier scale. By understanding your current cancer risk, you can identify appropriate measures such as lifestyle improvements and undergoing detailed examinations. 【Features】 ■ Blood test only ■ No prior preparation required ■ Short duration *For more details, please download the PDF or feel free to contact us.

• Contract Inspection